Lv1
100 积分 2025-10-14 加入
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
13天前
已完结
Balancing weight and muscle loss in GLP1 receptor agonist therapy
1个月前
已完结
A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 Consensus Update
3个月前
已完结
Meta-analysis of the Effect of Semaglutide on Blood Pressure in Obese Populations
3个月前
已完结
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes
3个月前
已关闭
Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
3个月前
已完结
The Efficacy and Safety of GLP-1 RAs in the Modification of Cardiovascular Morbidity in Patients with Obesity Without Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials Involving 32,884 Patients
3个月前
已关闭
Efficacy and safety of triple hormone receptor agonist retatrutide for the management of obesity: a systematic review and meta-analysis
3个月前
已完结
Efficacy and Safety of Subcutaneous and Oral GLP-1 Receptor/Dual Agonists on Weight Loss: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
3个月前
已关闭
#1700 Heterogeneity in characteristics of target population and definitions of renal outcome on evaluating the renoprotective effect of GLP-1RA in patients with diabetes: a systematic review and meta-analysis of observational studies versus randomized controlled trials
3个月前
已完结
皖公网安备34019202002308
